OSI-420 Chemical Properties

Melting point:

140-142°C

Density 

1.30

storage temp. 

-20°C Freezer

solubility 

insoluble in H2O; insoluble in EtOH; ≥51 mg/mL in DMSO

form 

A crystalline solid

color 

White to off-white

OSI-420 Usage And Synthesis

Description

Desmethyl erlotinib is a metabolite of erlotinib . Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity (IC₅₀ = 2.5 μM). This inhibits tumor growth in human head and neck carcinoma HN5 tumor xenografts in mice with an ED₅₀ value of 9 mg/kg. Erlotinib also suppresses cyclin-dependent kinase 2 (Cdk2) activity in breast cancer cells (IC₅₀ = 4.6 μM) and JAK2 mutant JAK2^V617F positive hematopoietic progenitor cells (IC₅₀ = 5 μM), which is associated with polycythemia vera, idiopathic myelofibrosis, and essential thrombocythemia. Formulations containing erlotinib have been used to treat certain forms of cancer, including non-small cell lung cancer.

Chemical Properties

Off-White Solid

Uses

A metabolite of Erlotinib (E625000), an anti cancer agent.

Uses

OSI-420 (Desmethyl Erlotinib,CP-473420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM for the inhibition of human EGFR and EGFR autophosphorylation in tumor cells.

References

[1] zhang w1, siu ll, moore mj, chen ex.simultaneous determination of osi-774 and its major metabolite osi-420 in human plasma by using hplc with uv detection. j chromatogr b analyt technol biomed life sci. 2005 jan 5;814(1):143-7.
[2] bonomi p. erlotinib: a new therapeutic approach for non-small cell lung cancer.expert opin investig drugs. 2003 aug;12(8):1395-401.

OSI-420(183321-86-0)Related Product Information

• OSI-420-d4, Free Base (Desmethyl Erlotinib-d4)
• Erlotinib IMpurity C
• Erlotinib
• Erlotinib Impurity 35
• 2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile
• Erlotinib Impurity 67
• Olmutinib
• XL-647
• Genistein
• AZD 3759
• AG 1478 HYDROCHLORIDE
• Anlotinib
• EGF816
• Tucatinib
• Neratinib
• Poziotinib (HM781-36B)
• CO-1686
• Dacomitinib (PF299804)